ReachMD

Popular

• • 

    

    Tim Rush

    Peer

  • 

    

    Bassam Rimawi, MD

    Peer

  9

  

  RestartResume

  Alternative Career Choices After Fellowship

• • 

    

    Neilanjan Nandi, MD, FACP

    Peer

  • 

    

    Millie D. Long, MD, MPH

    Peer

  25

  

  RestartResume

  New Perspectives on Biologic Therapy in Crohn’s Disease

• • 

    

    Sara Hurvitz, MD

    Peer

  • 

    

    Tiffany Traina, MD

    Peer

  • 

    

    William Mencia, MD

    Peer

  4

  

  RestartResume

  Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy

• • 

    

    Kristina Montemayor, MD

    Peer

  • 

    

    Natalie E. West, MD

    Peer

  • 

    

    Allison Lambert, MD

    Peer

  0

  

  RestartResume

  Catching Cystic Fibrosis: Key Diagnostic & Management Updates

• • 

    

    Warner K. Huh, MD

    Peer

  4

  

  RestartResume

  Long-Term Efficacy and Safety of HPV Vaccination

• • 

    

    Charlene A. Flash, MD, MPH

    Peer

  • 

    

    Don C. des Jarlais, PhD

    Peer

  1

  

  RestartResume

  Understanding the Growing Syndemic—Opioids, HCV, and HIV

• • 

    

    Thomas Ullman, MD

    Peer

  • 

    

    Juli Tomaino, MD

    Peer

  • 

    

    Sarah Yim, MD

    Peer

  2

  

  RestartResume

  Assessing Biosimilar Medications for Inflammatory Bowel Diseases

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Byron M. Thomashow, MD

    Peer

  • 

    

    Barbara Yawn, MD, MSc, FAAFP

    Peer

  2

  

  RestartResume

  Keys to Detecting COPD in the Primary Care Setting

• • 

    

    Reynold A. Panettieri, Jr., MD

    Peer

  • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  • 

    

    Jonathan Corren, MD

    Peer

  1

  

  RestartResume

  Advances in the Management of Difficult-to-Treat Asthma

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Randi J. Reidunsdatter, MD

    Peer

  1

  

  RestartResume

  Do Breast Cancer Patients & Oncologists Agree on the Severity of Symptoms Aft...

• • 

    

    John Anderson, MD

    Peer

  • 

    

    Vivian Fonseca, MD, FRCP

    Peer

  3

  

  RestartResume

  Glycemic Control in T2DM: Opportunities and Challenges

• • 

    

    Vivian Fonseca, MD, FRCP

    Peer

  • 

    

    John Anderson, MD

    Peer

  4

  

  RestartResume

  Glycemic Control in T2DM: Patient-Centric Approaches Case

• • 

    

    Andrew J. Solomon, MD

    Peer

  1

  

  RestartResume

  Multiple Sclerosis: An Immersive Virtual Patient Simulation

• • 

    

    John F. Brandsema, MD

    Peer

  3

  

  RestartResume

  Increasing Awareness and Access to Spinal Muscular Atrophy Therapy

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Ajai Chari, MD

    Peer

  3

  

  RestartResume

  The BiTE® Immuno-Oncology Platform & Emerging Targets in Oncology